HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 36 filers reported holding HORIZON PHARMA INVT LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $735,000 | +67.4% | 380,000 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $439,000 | -12.9% | 380,000 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $504,000 | +13.5% | 380,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $444,000 | +5.2% | 380,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $422,000 | -94.4% | 380,000 | -94.9% | 0.00% | -95.2% |
| Q3 2018 | $7,546,000 | +4.9% | 7,500,000 | 0.0% | 0.04% | -4.5% |
| Q2 2018 | $7,192,000 | +3.9% | 7,500,000 | 0.0% | 0.04% | -2.2% |
| Q1 2018 | $6,920,000 | -1.1% | 7,500,000 | 0.0% | 0.04% | +25.0% |
| Q4 2017 | $7,000,000 | +3.2% | 7,500,000 | 0.0% | 0.04% | -30.8% |
| Q3 2017 | $6,785,000 | +4.2% | 7,500,000 | 0.0% | 0.05% | +8.3% |
| Q2 2017 | $6,510,000 | -43.7% | 7,500,000 | -40.0% | 0.05% | -47.3% |
| Q1 2017 | $11,564,000 | -2.8% | 12,500,000 | 0.0% | 0.09% | -4.2% |
| Q4 2016 | $11,900,000 | -2.2% | 12,500,000 | 0.0% | 0.10% | +9.2% |
| Q3 2016 | $12,172,000 | +6.9% | 12,500,000 | 0.0% | 0.09% | +8.8% |
| Q2 2016 | $11,390,000 | +6.4% | 12,500,000 | 0.0% | 0.08% | +12.7% |
| Q1 2016 | $10,700,000 | – | 12,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|